NCT05009914

Brief Summary

This is a prospective, random controlled trial(RCT) study. 430 patients undergoing coronary artery bypass grafting were enrolled. Our new way of cardiac denervation, defined as excision of Marshall ligament and Waterstone fat pad, was performed in 215 patients, and the other 215 patients were used as control subjects. All the patients need to equip with electronic monitor to record heart rhythms within 6 days after CABG. The investigators will compare the incidence of postoperative atrial fibrillation between two groups, and follow up 30 days after discharged.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
430

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

August 15, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

1.3 years

First QC Date

June 29, 2021

Last Update Submit

May 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of POAF during hospital.

    Incidence of postoperative atrial fibrillation after surgery during hospital.

    6 days after surgery.

Secondary Outcomes (8)

  • Incidence of massive haemorrhage needing blood transfusion caused by cardiac denervation.

    Postoperative hospitalization, an average of 8 days.

  • Incidence of transferring to on-pump CABG caused by cardiac denervation.

    Intraoperatively.

  • Incidence of re-operation aiming to stop bleeding caused by cardiac denervation.

    Postoperative hospitalization, an average of 8 days.

  • Incidence of pericarial effusion within 30 days after discharged.

    within 30 days after discharged.

  • Incidence of arrhythmia exclude of AF within 30 days after discharged.

    within 30 days after discharged.

  • +3 more secondary outcomes

Study Arms (2)

cardiac denervation group

EXPERIMENTAL

In this group, patients undergoing CABG will receive the procedure of our new way of cardiac denervation, excision of Marshall ligament and Waterstone fat pad.

Procedure: cardiac denervation

controlled group

NO INTERVENTION

In this group ,patients undergoing CABG will not receive the procedure of cardiac denervation.

Interventions

Excision of Marshall ligament and Waterstone fat pad during CABG.

cardiac denervation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing simple CABG (on-pump/off-pump) for the first time.
  • Patients who signed the informed consent form and willing to undergo cardiac denervation.

You may not qualify if:

  • Age \< 18;
  • Emergent CABG;
  • Cardiac surgery history;
  • Receiving other cardiac surgery except of CABG at the same time, such as Morrow、valvular surgery、ventricular aneurysm surgery、congenital heart diseases surgery;
  • Requiring mechanical or pharmacological therapy for hemodynamic support before CABG, such as ECMO or IABP;
  • History of AF ;
  • Taking antiarrhythmic agents except of beta-blockers last 2 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, China

Location

Related Publications (1)

  • Yang Z, Tiemuerniyazi X, Xu F, Wang Y, Sun Y, Yan P, Tian L, Han C, Zhang Y, Pan S, Hu Z, Li X, Zhao W, Feng W. Partial Cardiac Denervation to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: The pCAD-POAF Randomized Clinical Trial. JAMA Cardiol. 2025 Jan 1;10(1):71-77. doi: 10.1001/jamacardio.2024.4639.

Study Officials

  • Wei Feng, MD PhD

    Chinese Academy of Medical Sciences, Fuwai Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

August 18, 2021

Study Start

August 15, 2022

Primary Completion

December 13, 2023

Study Completion

January 30, 2024

Last Updated

May 13, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations